Sorafenib increases efficacy of vorinostat against human hepatocellular carcinoma through transduction inhibition of vorinostat-induced ERK/NF-κB signaling

Author：              

Publisher： Spandidos Publications

ISSN： 1019-6439

Source： International Journal of Oncology, Vol.45, Iss.1, 2014-01, pp. : 177-188

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

TIPE2 inhibits TNF-α-induced hepatocellular carcinoma cell metastasis via Erk1/2 downregulation and NF-κB activation

By  

International Journal of Oncology, Vol. 46, Iss. 1, 2015-01 ,pp. : 254-264

Spandidos Publications

Access to resources Recommend Favorite

p62 participates in the inhibition of NF-κB signaling and apoptosis induced by sulfasalazine in human glioma U251 cells

By                

Oncology Reports, Vol. 34, Iss. 1, 2015-01 ,pp. : 235-243

Spandidos Publications

Access to resources Recommend Favorite

Radiosensitivity enhancement of human hepatocellular carcinoma cell line SMMC-7721 by sorafenib through the MEK/ERK signal pathway

By Dai Xiao-Fang   Ding Jie   Zhang Rui-Guang   Ren Jing-Hua   Ma C.-M. Charlie   Wu Gang  

International Journal of Radiation Biology, Vol. 89, Iss. 9, 2013-09 ,pp. : 724-731

Informa Healthcare

Access to resources Recommend Favorite

Vorinostat enhances the anticancer effect of oxaliplatin on hepatocellular carcinoma cells

By  

Cancer Medicine, Vol. 7, Iss. 1, 2018-01 ,pp. : 196-207

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effects of nuclear factor-κB and ERK signaling transduction pathway inhibitors on human melanoma cell proliferation in vitro

By          

Oncology Letters, Vol. 10, Iss. 5, 2015-01 ,pp. : 3233-3237

Spandidos Publications

Access to resources Recommend Favorite